MDMA, the FDA, and PTSD: A Missed Opportunity for Veterans?
As per the National Center for PTSD,
approximately 5% of adults in the United States experience PTSD in any given
year, which means around 13 million people suffer from this condition. Especially veterans who have experienced the horrors
of the war face PTSD or post-traumatic disorder in their everyday lives. For
decades, treatments like therapy and medication have been the go-to approaches.
However, according to the leading
mental health telemedicine providers, there are alternate treatment options for this condition, like the
MDMA (commonly known as Ecstasy). So, why isn’t the breakthrough treatment
available yet? Read on to find out!
(Source: https://www.ptsd.va.gov/understand/common/common_adults.asp )
MDMA’s
Therapeutic Potential for PTSD
When used in a therapeutic setting, MDMA can show
incredible promise for treating PTSD. How? Unlike conventional antidepressants,
which can take weeks to have an effect and often come with side effects,
MDMA-assisted therapy works swiftly to support patients in confronting their
traumatic memories without being overwhelmed by them. In fact, in clinical
trials, patients have also reported significant improvements after just a few
sessions, and many were able to reclaim their lives after years of battling
PTSD.
The
FDA’s Stance: Why the Delay?
If the treatment is such a game-changing option for
treating PTSD, are you wondering why the FDA is holding up MDA treatment? Well,
while the FDA has granted the “Breakthrough Therapy” designation to
MDMA-assisted therapy, it hasn’t yet approved the drug for widespread use.
Despite showcasing promising results in treating PTSD, MDMA is still classified
as a Schedule I drug in the U.S., which means it is considered to have “no
accepted medical use” and a high potential for abuse. The classification is
rooted in the outdated perspective of drug abuse, which has caused massive
barriers in the way of full FDA approval for MDMA.
Impact
on Veterans: A Waiting Game
There’s no denying that our veterans have given
everything to protect our country, yet many are left to suffer without the best
possible treatment for PTSD. There are existing therapies that fall short of
effect, and this has left veterans with persistent symptoms like flashbacks,
anxiety, and depression. In these situations, MDMA-assisted therapy could offer
veterans real relief. However, as the FDA drags its feet, veterans are left
with few options, hence resorting to less effective or even harmful treatments.
Think about how frustrating it would be for veterans
to know that a scientifically backed treatment exists but is out of reach
because of bureaucratic hurdles. Many veterans' organizations and mental health
advocates are pushing for the FDA to act swiftly, but the road to approval is
still uncertain.
Why
Aren’t We Moving Faster?
The FDA’s caution is understandable to some extent.
MDMA, after all, has a reputation as a party drug, and its misuse can lead to
serious consequences. However, in a controlled therapeutic setting with trained
professionals, MDMA has proven to be safe and effective. The problem is that
the FDA’s slow approval process doesn’t reflect the urgency of the situation.
PTSD is not a minor inconvenience—it’s a life-altering condition that can lead
to job loss, strained relationships, and even suicide.
Looking for approved treatment like MDMA or functional
medicine from therapists in Cedar Rapids or St Thomas, USVI? Contact the team at
Holistic Wellness & Psychiatry today!
This
content was originally published on: Holistic Wellness & Psychiatry PLLC
This has been
republished with permission.
Original
Source: https://holisticwellness.clinic/mdma-the-fda-and-ptsd-a-missed-opportunity-for-veterans/
Comments
Post a Comment